RRx-001, A novel dinitroazetidine radiosensitizer - Wikidata - awgldk - TriplyDB

RRx-001, A novel dinitroazetidine radiosensitizer

RRx-001, A novel dinitroazetidine radiosensitizer

http://www.wikidata.org/entity/Q26769671

about

Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets.The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury.RRx-001 protects against cisplatin-induced toxicities.

P2860

Q37045774-E2B39EE4-B60B-4F15-82C2-1F4A097AAC47 Q38817294-D96FC070-D452-4C96-91FA-3DB052707E8F Q46154170-EA97D6AF-86B6-45B8-9C3C-8F1FD37CE354

P2860

RRx-001, A novel dinitroazetidine radiosensitizer

http://www.wikidata.org/entity/Q26769671

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

RRx-001, A novel dinitroazetidine radiosensitizer

@ast

RRx-001, A novel dinitroazetidine radiosensitizer

@en

RRx-001, A novel dinitroazetidine radiosensitizer

@nl

type

label

RRx-001, A novel dinitroazetidine radiosensitizer

@ast

RRx-001, A novel dinitroazetidine radiosensitizer

@en

RRx-001, A novel dinitroazetidine radiosensitizer

@nl

prefLabel

RRx-001, A novel dinitroazetidine radiosensitizer

@ast

RRx-001, A novel dinitroazetidine radiosensitizer

@en

RRx-001, A novel dinitroazetidine radiosensitizer

@nl

P1433

Q26769671-C29ADC02-FD07-4A91-A46A-2E5D038A881E

P1476

Q26769671-49B01FDC-0DC8-4FBB-B716-0E95E216285F

P2093

Q26769671-2F5BFFA2-D75E-473A-B38C-CD2F1E7590DE

Q26769671-5AD77571-F963-439E-83EC-364BACC5D9C9

Q26769671-C12A5D8D-EEF5-40A8-AF21-F7176F3855E8

Q26769671-C1E85E87-9812-4099-A5A1-65A672A8DD0E

Q26769671-CDA4A99D-79D3-4870-8651-7E412FD2C315

Q26769671-D274D869-E13E-4255-BEF6-B390A1F9408C

P275

Q26769671-54CCEF5B-1953-4517-AB8F-41E931E647F6

P2860

Q26769671-01301E92-9513-4EEE-8386-44CCBDC97F55

Q26769671-030100FA-C90F-4186-9E4B-F6548DC188D2

Q26769671-119B604F-657A-48A6-8488-ED3F5B3214AF

Q26769671-135BD03F-0FD4-4B60-8C38-E04A0FF7BB98

Q26769671-21C5FE26-3D01-46C8-A74E-7A380843970E

Q26769671-279A8F33-14F9-44D6-95C6-0E8AF9AA823E

Q26769671-4694C691-FFDB-4ADE-8542-8D3466408246

Q26769671-46FE8CC4-F953-402C-972F-1C6CB02E88DE

Q26769671-482BA86B-3D01-4AAD-974E-4185A8C9A620

Q26769671-4FD9399F-A004-4AB5-8F72-DEF6EF4DD144

P2888

Q26769671-A52A84DA-29C1-4BE5-A199-2CF1F2812DE3

P304

Q26769671-6D04C331-FFF9-48B3-B700-ABF456E7317B

P31

Q26769671-1002E53A-B8B6-49B8-BFDB-DB11CA8635E4

Q26769671-D00B691A-30F7-4A00-8981-8E130F4B3400

P3181

Q26769671-AE18F9F5-1E40-45AF-9963-BB4D1DA29CBC

P356

Q26769671-A553B817-B789-42A8-A18C-1DFD91FC7B84

P407

Q26769671-2A6A9D4D-DA66-4757-8174-281056CCDD31

P433

Q26769671-5129B304-A4C5-4D19-B3DF-7EF375F81E7D

P478

Q26769671-D5FAD497-E6FA-4505-8679-E6523EB2D60D

P50

Q26769671-3AA7995A-C1CC-411E-9667-0FDC7EFCD66E

Q26769671-7C9ABCC0-3461-4599-B3D0-5555B273DAB0

P5008

Q26769671-34E95558-D4FC-4C3A-948C-8A1A42736C3A

P577

Q26769671-583F4802-C0B7-4B39-956B-31180D740C90

Q26769671-83B671E0-7EED-49CD-A2C1-28BCA027F10D

P5875

Q26769671-12D13FF8-13A0-434F-A7BC-1A52EF02C008

P6179

Q26769671-49C77894-B605-4AC1-A666-C06F6F0852F3

P698

Q26769671-D75F4D0C-70CE-4502-9E66-0C10A6F23998

P921

Q26769671-3EF4F1E9-4E10-4DC3-ACC2-4E6E328108E1

Q26769671-7820B90D-7027-42BD-9754-2772872ABF71

Q26769671-EB8A0942-8517-41E4-8043-24778A57ED0B

P932

Q26769671-FEDDA666-4126-4D26-B61D-876F86CAFFF6

P3181

P356

S10637-016-0326-Y

P1433

Investigational New Drugs

P1476

RRx-001, A novel dinitroazetidine radiosensitizer

@en

P2093

Arnold Oronsky

http://www.w3.org/2001/XMLSchema#string

Donna Peehl

http://www.w3.org/2001/XMLSchema#string

Jan Scicinski

http://www.w3.org/2001/XMLSchema#string

Mark Bednarski

http://www.w3.org/2001/XMLSchema#string

Shoucheng Ning

http://www.w3.org/2001/XMLSchema#string

Susan Knox

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Distribution and Fate of Military Explosives and Propellants in Soil: A Review

Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations

NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001

A short history of nitroglycerine and nitric oxide in pharmacology and physiology

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.

Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase

After 130 years, the molecular mechanism of action of nitroglycerin is revealed.

P2888

s10637-016-0326-y

P304

371-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1383608

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10637-016-0326-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292943783

http://www.w3.org/2001/XMLSchema#string

P6179

1007004307

http://www.w3.org/2001/XMLSchema#string

P698

26841903

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

4859863

http://www.w3.org/2001/XMLSchema#string